TY - JOUR
T1 - The Texas collaborative center for hepatocellular cancer
T2 - Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy
AU - Harrison, Ariel C.
AU - Kanwal, Fasiha
AU - Asrani, Sumeet K.
AU - Thrift, Aaron P.
AU - Amos, Chris I.
AU - Jibaja-Weiss, Maria L.
AU - Montealegre, Jane R.
AU - Hwang, Jessica P.
AU - Singal, Amit G.
AU - El-Serag, Hashem B.
N1 - Publisher Copyright:
Copyright © 2022 Harrison, Kanwal, Asrani, Thrift, Amos, Jibaja-Weiss, Montealegre, Hwang, Singal and El-Serag.
PY - 2022/8/19
Y1 - 2022/8/19
N2 - Texas has the highest age-adjusted incidence rate of hepatocellular carcinoma (HCC) in the United States. To address cancer prevention and early detection through research, Cancer Prevention and Research Institute of Texas (CPRIT) has funded the Texas Collaborative Center for Hepatocellular Cancer (TeCH) to facilitate liver cancer research, education and advocacy activities. This paper describes the organizational structure, program measures, the actions completed and future plans of TeCH. This center is comprised of several cores and committees including the Administrative Core, Steering Committee, Data and Biospecimen Core, Scientific Committee, Clinical Network Committee, and the Community Outreach Committee. Each core and committee provide its own level of connectivity and necessary research support. We have developed and published a TeCH Framework, a conceptual model designed for improving primary and secondary prevention of HCC. TeCH and its committees facilitate connections and collaborations among HCC researchers and clinicians, healthcare leaders, biotechnology companies and the public to reduce liver cancer mortality in Texas by 2030.
AB - Texas has the highest age-adjusted incidence rate of hepatocellular carcinoma (HCC) in the United States. To address cancer prevention and early detection through research, Cancer Prevention and Research Institute of Texas (CPRIT) has funded the Texas Collaborative Center for Hepatocellular Cancer (TeCH) to facilitate liver cancer research, education and advocacy activities. This paper describes the organizational structure, program measures, the actions completed and future plans of TeCH. This center is comprised of several cores and committees including the Administrative Core, Steering Committee, Data and Biospecimen Core, Scientific Committee, Clinical Network Committee, and the Community Outreach Committee. Each core and committee provide its own level of connectivity and necessary research support. We have developed and published a TeCH Framework, a conceptual model designed for improving primary and secondary prevention of HCC. TeCH and its committees facilitate connections and collaborations among HCC researchers and clinicians, healthcare leaders, biotechnology companies and the public to reduce liver cancer mortality in Texas by 2030.
KW - cancer prevention
KW - collaborative center
KW - hepatocellular cancer (HCC)
KW - liver cancer
KW - Texas
UR - http://www.scopus.com/inward/record.url?scp=85137703575&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85137703575&partnerID=8YFLogxK
U2 - 10.3389/fonc.2022.953933
DO - 10.3389/fonc.2022.953933
M3 - Article
C2 - 36059708
AN - SCOPUS:85137703575
SN - 2234-943X
VL - 12
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 953933
ER -